The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
CHAI started supporting Indonesia’s Ministry of Health in 2010 to scale up adult anti-retroviral therapy, through improving supply chain management; as well as technical assistance for improving the quality of ART and laboratory systems to support HIV care and treatment. In recent years, CHAI has expanded its support to the Ministry of Health to other areas including hepatitis and helping to facilitate BMS to and donate pan genotyping DAA, daclatasvir, more effective treatment for HCV patient, improving access to family planning, point of care diagnostics, mhealth, maternal and child health, and technical support for the Ministry of Health’s drive to sustainably fund healthcare. In mid-2016, CHAI launched its vaccines program to introduce new vaccine introduction, PCV, to EPI, Ministry of Health Indonesia, The focus of the program is to support the EPI in new vaccine introductions, assisting the government to make an-informed and coordinated decision on PCV introduction
Overview of the CHAI Indonesia Vaccines Work
In mid-2016, CHAI launched its vaccines program to support the Expanded Program on Immunization (EPI) and the Indonesian Ministry of Health (MoH) to accelerate the introduction of PCV vaccine- specifically focusing on assisting the government to make an-informed and coordinated decision on PCV introduction. Vaccination is widely acknowledged as one of the most cost-effective and focused disease interventions. In addition, the unprecedented wave of new vaccines expected over the next decade has the potential to dramatically reduce the global burden of disease. The EPI faces several challenges in its attempt to introduce new vaccines like PCV. For example, as Indonesia is no longer eligible (as of 2018) for Gavi funding assistance, the EPI has to mobilize funding for the procurement of costly new vaccines as well as strengthen its immunization system to deliver vaccines effectively. CHAI expanded its support to MoH to manage the transition from Gavi funding and address associated system management gaps. Barriers to introducing PCV and other life-saving vaccines include: lack of adequate data and access to the evidence needed to inform the decision of whether and on how to optimally introduce PCV; a challenging country context with a fragmented and devolved government structure, and an imminent transition out of Gavi support. CHAI will help the government make a well-informed and coordinated decision on immunization comprehensive planning and budgeting including NVI. CHAI support EPI with strengthening immunization system including strengthening budget planning, cold chain infrastructure, cold chain management and supply chain systems in order to ensure that newly introduced and routine vaccines are a) available to children b) stored and transported in potent condition and c) delivered to the population in an efficient manner.
CHAI’s proposed work will be focused on six complementary strategic goals:
1. Improving affordability and supply security of immunization products especially PCV and other new vaccine;
2. Accelerating the uptake of new or under-utilized vaccines;
3. Enhancing the performance of vaccine cold chain and logistics systems to increase effective immunization coverage;
4. Improving the design and implementation of service delivery to reach the unreached
5. Supporting successful transition from Gavi support; and
6. Strengthening the management system and capacity of immunization program.